FR1461230A - Procédé de préparation d'analogues de la céphalosporine c et nouveaux dérivés en résultant - Google Patents

Procédé de préparation d'analogues de la céphalosporine c et nouveaux dérivés en résultant

Info

Publication number
FR1461230A
FR1461230A FR43470A FR43470A FR1461230A FR 1461230 A FR1461230 A FR 1461230A FR 43470 A FR43470 A FR 43470A FR 43470 A FR43470 A FR 43470A FR 1461230 A FR1461230 A FR 1461230A
Authority
FR
France
Prior art keywords
cephalosporin
analogues
preparation
novel derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR43470A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of FR1461230A publication Critical patent/FR1461230A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR43470A 1964-12-23 1965-12-23 Procédé de préparation d'analogues de la céphalosporine c et nouveaux dérivés en résultant Expired FR1461230A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52288/64A GB1141293A (en) 1964-12-23 1964-12-23 Cephemoic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
FR1461230A true FR1461230A (fr) 1966-12-10

Family

ID=10463355

Family Applications (1)

Application Number Title Priority Date Filing Date
FR43470A Expired FR1461230A (fr) 1964-12-23 1965-12-23 Procédé de préparation d'analogues de la céphalosporine c et nouveaux dérivés en résultant

Country Status (9)

Country Link
US (1) US3532694A (fr)
AT (1) AT269352B (fr)
BE (1) BE674255A (fr)
CH (1) CH478135A (fr)
DE (1) DE1545927A1 (fr)
FR (1) FR1461230A (fr)
GB (1) GB1141293A (fr)
NL (1) NL149176B (fr)
SE (1) SE351654B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073304A1 (fr) * 1969-09-22 1971-10-01 Yamanouchi Pharma Co Ltd

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864338A (en) * 1970-08-11 1975-02-04 Squibb & Sons Inc Process for the preparation of {66 {hu 2{b -cephalosporin aldehydes
SE412238B (sv) * 1971-05-24 1980-02-25 Ciba Geigy Forfarande for framstellning av 7 beta-amino-cefem-4-karboxylsyraforeningar genom dekarbonylering av en 3-formyl-cefem-4-karboxylsyraforening
ES436565A1 (es) * 1974-06-05 1977-04-01 Bristol Myers Co Un procedimiento para la preparacion de acidos acetamidope- nicilanicos.
DK159154C (da) 1975-02-24 1991-02-11 Takeda Chemical Industries Ltd Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
GB1571989A (en) * 1976-10-08 1980-07-23 Glaxo Lab Ltd Manufacture of 3-hydroxymethyl cephalosporin compounds
EP0089216A3 (fr) * 1982-03-15 1984-11-21 Glaxo Group Limited Dérivés de céphalosporine
US4584371A (en) * 1984-03-01 1986-04-22 The Upjohn Company Catalytic process for preparing 3-ester-methyl cephalosporins from desacetyl-7-aminocephalosporanic acid
US4908444A (en) * 1986-01-23 1990-03-13 Takeda Chemical Industries, Ltd. Method of producing cephem compounds
US5112967A (en) * 1990-04-27 1992-05-12 Hoffmann-La Roches Inc. Process for synthesizing antibacterial cephalosporin compounds
US5066800A (en) * 1990-04-27 1991-11-19 Hoffmann-La Roche Inc. Qunoline intermediates useful therein for synthesizing antibacterial compounds
US5221739A (en) * 1992-01-09 1993-06-22 Eli Lilly And Company Acetylation of 3-hydroxymethyl cephalosporins
US5512454A (en) * 1994-02-03 1996-04-30 Bristol-Myers Squibb Company Enzymatic acylation of 3-hydroxymethyl cephalosporins
EP1044205A4 (fr) * 1997-10-30 2001-12-05 Bristol Myers Squibb Co Acetylation de desacetyl-cephalosporines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1012943A (en) * 1961-05-16 1965-12-15 Glaxo Lab Ltd Improvements in or relating to antibiotics
US3270009A (en) * 1961-08-23 1966-08-30 Lilly Co Eli Carbocyclic-substituted aliphatic cephalosporins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073304A1 (fr) * 1969-09-22 1971-10-01 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
GB1141293A (en) 1969-01-29
CH478135A (de) 1969-09-15
NL6516708A (fr) 1966-06-24
SE351654B (fr) 1972-12-04
NL149176B (nl) 1976-04-15
DE1545927A1 (de) 1970-01-22
BE674255A (fr) 1966-06-23
US3532694A (en) 1970-10-06
AT269352B (de) 1969-03-10

Similar Documents

Publication Publication Date Title
CH513193A (fr) Procédé de préparation de nouveaux dérivés de l'hydroxy-méthyl-5 oxazolidinone-2
CH475234A (fr) Procédé de préparation de nouveaux dérivés de l'hydroxy-4-coumarine
CH453334A (fr) Procédé de préparation de nouveaux dérivés de l'urée et de la thiourée
FR1367450A (fr) Procédé de préparation de dérivés d'isothiazolyl-lithium
FR1502971A (fr) Procédé de préparation de nouveaux dérivés d'alanine
FR1458956A (fr) Procédé de préparation de nouveaux dérivés d'hydrazine
FR1507525A (fr) Procédé de préparation d'imino-dérivés de 5-nitro-(2)-furfurylidène
FR1339406A (fr) Procédé de préparation de nouveaux dérivés de 6-méthylergoline pi et de 1, 6-diméthylergoline pi
FR1456255A (fr) Procédé de préparation de dérivés d'iminopyrrolidines
CH474532A (fr) Procédé de préparation de dérivés d'oxazole
CH438359A (fr) Procédé de préparation de nouveaux dérivés de l'acétamidine
CH450435A (fr) Procédé de préparation de l'hypoxanthine et de dérivés de celle-ci
FR1313469A (fr) Procédé de préparation d'alcoylidène bis-dibromophénols
BE636687A (fr) Procédé de préparation de dérivés de l'isothiorée
FR1467942A (fr) Procédé de préparation de dérivés nu-disubstitués de l'aminoacétamide et nouveaux dérivés de ce type
FR1417961A (fr) Procédé de préparation de dérivés d'hydroxy-xanthones
CH422809A (fr) Procédé de préparation de l'inosine et de dérivés de celle-ci
FR1518386A (fr) Procédé de préparation d'aza-dioxa-bicyclo-alcanes
CH415682A (fr) Procédé de préparation de nouveaux dérivés d'acides alkényloxybenzoïques
FR1373273A (fr) Procédé de préparation de nouveaux dérivés de la céphalosporine c
CH421976A (fr) Procédé de préparation de nouveaux dérivés de l'hydantoïne
CH423781A (fr) Procédé de préparation de nouveaux dérivés de l'oxazolidinone-2
BE630294A (fr) Procédé de préparation de dérivés basiquement substitués d'alkylxanthine
FR1362095A (fr) Procédé de préparation d'halophospholines et de leurs dérivés
CH510670A (fr) Procédé de préparation de nouveaux dérivés de l'amidobenzamide